HEL-LUC Cell line

HEL Luciferase Cell Line engineered for stable, high-efficiency expression of the luciferase gene.This advanced tool delivers exceptionally high imaging quality and precise, quantifiable luminescence, ensuring your data is both robust and publication-ready.
Designed for versatility, the HEL Luciferase Cell Line seamlessly adapts to a broad spectrum of applications—from promoter activity assays and mammalian two-hybrid studies to sophisticated in vivo imaging.
HEL cell line is a lymphoblastoid cell line derived from a 30-year-old Caucasian male. This patient suffered from malignant erythroleukemia, capable of naturally producing and inducing globulin synthesis. HEL cells are negative for Epstein-Barr virus nuclear antigen, lacking surface immunoglobulin and cytoplasmic immunoglobulin. HEL cells express HLA antigens (HLA-A3, AW32, BW35), β-2 microglobulin, and a certain proportion of cells also express La antigen. HEL cells provide a model for studying erythroid differentiation and globulin gene expression, which is similar to hemophilia in mice.